Contact UsCompany ProfileHome
Saaskin Technologies
Send Inquiry Send SMS    Call Me Free
Boditech AFIAS Infliximab Boditech AFIAS Infliximab Boditech AFIAS Infliximab
Boditech AFIAS Infliximab
Boditech AFIAS Infliximab Boditech AFIAS Infliximab

Boditech AFIAS Infliximab

Product Details:

  • Storage Instructions Store at 2-8C, protect from direct sunlight
  • Function Quantitative determination of infliximab levels
  • Instruments Type IVD Cartridge for use with Boditech AFIAS system
  • Accuracy Clinical accuracy and sensitivity validated
  • Shelf Life As per manufacturer: typically up to 12 months
  • Display Type Analyzer-dependent
  • Features Single-use, quantitative, rapid, reliable, easy handling
  • Click to View more
X

Boditech AFIAS Infliximab Price And Quantity

  • Analyzer auto-calibrated via cartridge barcode
  • Single-use
  • Fluorescent-labeled antibody for infliximab
  • Serum
  • Specified in kit insert
  • Approximately 10-20 minutes per run
  • CE-IVD approved
  • Digital, quantitative
  • Test cartridge, buffer, desiccant pouch, instruction leaflet
  • Individually foil packed
  • Barcode on each cartridge
  • AFIAS Analyzer
  • Exclusive for Boditech AFIAS platforms
  • Therapeutic drug monitoring for patients treated with infliximab (Remicade®)

Boditech AFIAS Infliximab Product Specifications

  • White with printed labels
  • Single-use, quantitative, rapid, reliable, easy handling
  • Infliximab assessment in serum
  • Yes
  • Silent
  • Laboratory in-vitro diagnostics
  • Dependent on analyzer
  • Fluorescent ImmunoAssay (FIA)
  • Analyzer-dependent
  • According to kit insert & analyzer
  • IVD Diagnostic Cartridge
  • Cartridge size compatible with AFIAS system
  • No
  • Cartridge is portable; analyzer may not be
  • Clinical accuracy and sensitivity validated
  • Compatible Boditech AFIAS analyzer (external power required)
  • As per manufacturer: typically up to 12 months
  • Analyzer-dependent
  • New
  • Automatic/Manual (Instrument Required)
  • Quantitative determination of infliximab levels
  • Single-use, lightweight cartridge
  • Store at 2-8C, protect from direct sunlight
  • IVD Cartridge for use with Boditech AFIAS system
  • Medical-grade plastic and electronic components
  • Analyzer auto-calibrated via cartridge barcode
  • Single-use
  • Fluorescent-labeled antibody for infliximab
  • Serum
  • Specified in kit insert
  • Approximately 10-20 minutes per run
  • CE-IVD approved
  • Digital, quantitative
  • Test cartridge, buffer, desiccant pouch, instruction leaflet
  • Individually foil packed
  • Barcode on each cartridge
  • AFIAS Analyzer
  • Exclusive for Boditech AFIAS platforms
  • Therapeutic drug monitoring for patients treated with infliximab (Remicade®)

Product Description

Brand                   Boditech

Sample Type       Serum/ Plasma/ WB

SMFP-74              24T

CAT No                SMFP-75

Biomarker           Therapeutic Drug Monitoring

Therapeutic Drug Monitoring (TDM) is to optimize biologic treatment for an individual patient. AFIAS Infliximab allows for reliable measurement of Infliximab drug levels using just a small amount of human serum, plasma, or whole blood, delivering results in 10 minutes. This allows clinicians to confirm the drug levels of Infliximab immediately before the next administration.



Precise Therapeutic Drug Monitoring

The AFIAS Infliximab test delivers clinically validated, quantitative measurement of infliximab levels in serum. This enables healthcare providers to effectively monitor therapy, ensure optimal dosing, and enhance patient outcomes. The assay is highly reliable due to its fluorescence-based detection and analyzer-driven calibration.


Rapid, Easy, and Reliable Operation

With a turnaround time of only 10-20 minutes, the AFIAS Infliximab cartridge lets laboratories act quickly. Designed for ease of handling, the single-use kit minimizes risks of cross-contamination and user error. Automated calibration ensures high consistency, while digital output makes interpretation straightforward.


Seamless AFIAS System Compatibility

Engineered for exclusive use with Boditech AFIAS analyzers, the cartridge integrates smoothly into your existing workflow. Each cartridge features barcode-based traceability and is stored at 2-8C for longevity. Compact and portable, the test supports flexible laboratory practice while upholding rigorous diagnostic standards.

FAQ's of Boditech AFIAS Infliximab:


Q: How does the Boditech AFIAS Infliximab test work?

A: The AFIAS Infliximab test employs a fluorescent-labeled antibody to quantitatively measure infliximab levels in serum. Once the sample is added to the cartridge and inserted into a compatible Boditech AFIAS Analyzer, the system automatically calibrates via cartridge barcode and provides digital results within 10-20 minutes.

Q: What are the main benefits of using the AFIAS Infliximab cartridge for drug monitoring?

A: This single-use, quantitative cartridge provides rapid, accurate results, supports precise therapeutic management, simplifies workflow with auto-calibration, and reduces cross-contamination risks. Its digital output ensures easy integration with laboratory processes and enhanced decision-making for infliximab therapy adjustments.

Q: When and where should the AFIAS Infliximab test be used?

A: The test is intended for laboratory use to monitor serum infliximab levels in patients undergoing Remicade therapy. It is suitable when timely dose adjustments are required for optimal therapeutic outcomes, and is designed exclusively for use in conjunction with the Boditech AFIAS Analyzer.

Q: What components are included in the AFIAS Infliximab kit?

A: Each kit contains a single-use test cartridge, buffer, desiccant pouch, and instruction leaflet. The cartridge is individually foil-packed and features a barcode for lot traceability. An AFIAS Analyzer instrument is required for processing the test.

Q: How should the AFIAS Infliximab test cartridge be stored and handled?

A: Store the cartridge at 2-8C and protect it from direct sunlight. Allow the cartridge to reach room temperature before use, and ensure it is not expired by checking the shelf life as indicated by the manufacturer.

Q: What is the detection principle and how is accuracy assured?

A: The test operates on the Fluorescent ImmunoAssay (FIA) principle, using fluorescent-labeled antibodies specific for infliximab. Accuracy and sensitivity are clinically validated, with automated instrument calibration ensuring consistent and reliable results.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

Other Products in 'Medical FIA' category



trade india member
SAASKIN CORPORATION PRIVATE LIMITED All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Private Limited.